Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Chapel

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Immunology|November 30, 1999
Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological SocietiesH M Chapel
The Quarterly Journal of Medicine|February 1, 1993
Hypogammaglobulinaemia and replacement therapyH M Chapel
Nature|November 18, 1976
Rosette formation by human lymphocytesH M Chapel
BMJ (Clinical Research Ed.)|February 26, 1994
Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody DeficienciesH M Chapel
Transplantation|March 1, 1973
The effects of papain, trypsin and phospholipase A on rosette formationH M Chapel
Clinical and Experimental Immunology|December 21, 2004
Primary immune deficiencies--improving our understanding of their role in immunological diseaseH M Chapel
Immunodeficiency|January 1, 1993
UK register of patients on home intravenous immunoglobulin therapyV Brennan, H M Chapel
Clinical and Experimental Immunology|November 1, 1990
Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitidesW Egner, H M Chapel
Journal of Clinical Immunology|January 1, 1992
Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolismH M Chapel, M Lee
Clinical and Experimental Immunology|July 1, 1994
The use of intravenous immune globulin in multiple myelomaH M Chapel, M Lee
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Immunology|November 30, 1999
Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological SocietiesH M Chapel
The Quarterly Journal of Medicine|February 1, 1993
Hypogammaglobulinaemia and replacement therapyH M Chapel
Nature|November 18, 1976
Rosette formation by human lymphocytesH M Chapel
BMJ (Clinical Research Ed.)|February 26, 1994
Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody DeficienciesH M Chapel
Transplantation|March 1, 1973
The effects of papain, trypsin and phospholipase A on rosette formationH M Chapel
Clinical and Experimental Immunology|December 21, 2004
Primary immune deficiencies--improving our understanding of their role in immunological diseaseH M Chapel
Immunodeficiency|January 1, 1993
UK register of patients on home intravenous immunoglobulin therapyV Brennan, H M Chapel
Clinical and Experimental Immunology|November 1, 1990
Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitidesW Egner, H M Chapel
Journal of Clinical Immunology|January 1, 1992
Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolismH M Chapel, M Lee
Clinical and Experimental Immunology|July 1, 1994
The use of intravenous immune globulin in multiple myelomaH M Chapel, M Lee
Pageof 9